Anastasia Zekeridou
@anastasiaz.bsky.social
Autoimmune Neurologist at Mayo Clinic, Personal account
Can we use these biomarkers to aid our patients? I think we can… They have limitations but can be useful in many scenarios! More to come…
September 10, 2025 at 5:39 PM
Can we use these biomarkers to aid our patients? I think we can… They have limitations but can be useful in many scenarios! More to come…
And Dr Aboseif’s work on LGI1 autoimmunity recently published… onlinelibrary.wiley.com/doi/10.1002/...
Cytokine, Chemokine, and Neurofilament Light Chain Signatures in LGI1 Autoimmune Encephalitis
Objectives To investigate the value of cytokine, chemokine, and neurofilament light chain (NfL) concentrations in predicting relapse risk, chronic epilepsy, and functional impairment in LGI1 autoimm...
onlinelibrary.wiley.com
September 10, 2025 at 5:39 PM
And Dr Aboseif’s work on LGI1 autoimmunity recently published… onlinelibrary.wiley.com/doi/10.1002/...
Followed by the work of Dr Yahel Segal in GFAP autoimmunity aiding diagnosis and pathophysiological insights… onlinelibrary.wiley.com/doi/10.1002/...
CSF cytokine, chemokine and injury biomarker profile of glial fibrillary acidic protein (GFAP) autoimmunity
Defining the CSF cytokine/chemokine and injury biomarker signature of glial fibrillary acidic protein (GFAP) autoimmunity can inform immunopathogenesis. CSF GFAP-IgG-positive samples (N = 98) were te....
onlinelibrary.wiley.com
September 10, 2025 at 5:39 PM
Followed by the work of Dr Yahel Segal in GFAP autoimmunity aiding diagnosis and pathophysiological insights… onlinelibrary.wiley.com/doi/10.1002/...